Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
After a slow 2024, dealmaking in the U.S. healthcare sector is picking up. Springworks has a market value of $3 billion.
It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback